naproxen- naproxen tablet
nucare pharmaceuticals, inc. - naproxen (unii: 57y76r9atq) (naproxen - unii:57y76r9atq) - carefully consider the potential benefits and risks of naproxen tablets and other treatment options before deciding to use naproxen tablets. use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals ( see warnings: gastrointestinal bleeding, ulceration, and perforation ). naproxen tablets are indicated: - for the relief of the signs and symptoms of rheumatoid arthritis - for the relief of the signs and symptoms of osteoarthritis - for the relief of the signs and symptoms of ankylosing spondylitis - for the relief of the signs and symptoms of juvenile arthritis naproxen tablets are also indicated: - for relief of the signs and symptoms of tendonitis - for relief of the signs and symptoms of bursitis - for relief of the signs and symptoms of acute gout - for the management of pain - for the management of primary dysmenorrhea naproxen tablets are contraindicated in the following patents: - known hypersensitivity (e.g., anaphylactic reactions and serious skin rea
naproxen- naproxen tablet
nucare pharmaceuticals, inc. - naproxen (unii: 57y76r9atq) (naproxen - unii:57y76r9atq) - carefully consider the potential benefits and risks of naproxen tablets and other treatment options before deciding to use naproxen tablets. use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals ( see warnings: gastrointestinal bleeding, ulceration, and perforation ). naproxen tablets are indicated: - for the relief of the signs and symptoms of rheumatoid arthritis - for the relief of the signs and symptoms of osteoarthritis - for the relief of the signs and symptoms of ankylosing spondylitis - for the relief of the signs and symptoms of juvenile arthritis naproxen tablets are also indicated: - for relief of the signs and symptoms of tendonitis - for relief of the signs and symptoms of bursitis - for relief of the signs and symptoms of acute gout - for the management of pain - for the management of primary dysmenorrhea naproxen tablets are contraindicated in the following patents: - known hypersensitivity (e.g., anaphylactic reactions and serious skin rea
bio-life coq10 300 mg soft capsules
mega lifesciences (australia) pty ltd - ubidecarenone, quantity: 300 mg - capsule, soft - excipient ingredients: lecithin; white beeswax; glycerol; gelatin; soya oil; purified water; titanium dioxide; iron oxide black; brilliant blue fcf; brilliant scarlet 4r - helps enhance/promote healthy blood circulation ; maintain/support heart health
bio-life coq10 150mg capsule
bio-life marketing sdn bhd - coenzyme q10 (ubidecarenone) -
bio-life q10 plus zinc & vit e soft capsule
mega lifesciences sdn. bhd. - coenzyme q10 (ubidecarenone); d-alpha tocopherol; zinc amino acid chelate -
bio-life coq10 300 mg soft capsules
bio-life marketing sdn bhd - coenzyme q10 (ubidecarenone) -
life q- sodium bicarbonate tablet
saenggi life - sodium bicarbonate (unii: 8mdf5v39qo) (bicarbonate ion - unii:hn1zra3q20) - hand sanitizer virus, bacteria, bacteria removal and infection prevention effect from all spaces and objects in daily life. recommended for repeated use. - do not eat. - do not spray directly on the body.
cholecalciferol pharmacare 10,000 iu soft capsules
pharmacare srl via marghera, 29 20149, milan, italy - soft capsule - colecalciferol 10000 iu - vitamins
cholecalciferol pharmacare 25,000 iu soft capsules
pharmacare srl via marghera, 29 20149, milan, italy - soft capsule - colecalciferol 25000 iu - vitamins
life technologies applied biosystems™ taqpath™ covid‑19 ht kit
life technologies holdings pte ltd - microbiology - applied biosystems™ taqpath™ covid‑19 ht kit is the high‑throughput format of the taqpath™ covid‑19 ce‑ivd rt‑pcr kit. the kit is intended for use with the magmax™ viral/pathogen ii nucleic acid isolation kit, high‑throughput and is compatible with the amplitude™ platform. the kit contains the reagents and controls for a real‑time reverse transcription polymerase chain reaction (rt‑pcr) test intended for the qualitative detection of nucleic acid from sars‑cov‑2 in upper respiratory specimens (nasopharyngeal and nasal) from individuals suspected of covid-19.